yes, possibly
but big pharma is about profit & they are not going to takeover EMS for $XXXXXXXXXX when the product is simply an "improvement" on their current products & production systems
all i am saying is selling Artimist will not be something simple and big pharma will not pay really big dollars to buy Artimist when it provides a small benefit over existing treatments
don't over-dream
had a conversation with steve yesterday, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
